News >

Emerging Combos Lead to More Questions, Research Efforts in Advanced HCC

Jessica Hergert
Published: Wednesday, Feb 19, 2020

James J. Harding, MD

James J. Harding, MD

After years of little advancement, novel agents and combination strategies are now introducing paradigm-shifting options for the treatment patients with advanced or metastatic hepatocellular carcinoma (HCC), said James J. Harding, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication